Trial intelligence / Profile preview

Tolerability of Once Daily Lopinavir/Ritonavir Liquid vs Capsules

NCT00281606Phase 4Completed

Sponsor
University of California, San Diego
Start
Feb 2006
Primary completion
Oct 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by University of California, San Diego. Started Feb 2006; status: completed.

02

Drugs

lopinavir + ritonavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00281606.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00281606.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call